MedPath

A study to analyse relationship between gut microbiome and different types of lung cancers

Not Applicable
Conditions
Health Condition 1: C00-D49- Neoplasms
Registration Number
CTRI/2023/04/051268
Lead Sponsor
Bhaktivedanta Hospital and Research Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients who have lung cancer with EGFR activating mutations.

Exclusion Criteria

Patient who is not able to provide stool sample for analysis

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The different microbiota in different percentage present in EGFR positive lung cancers will establish that diet forms a major contributing factor in non-smoking related lung cancers. <br/ ><br>Timepoint: The outcome will be assessed at 4 weeks for the duration of 1 year
Secondary Outcome Measures
NameTimeMethod
ATimepoint: NA
© Copyright 2025. All Rights Reserved by MedPath